1.	Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer Phase: Phase IV Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 30 to 65 Sponsor: Other Protocol IDs: 88-04-27-9683, NCT01049295
2.	A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) Phase: Phase IV Type: Supportive care Status: Active Age: 20 to 79 Sponsor: Pharmaceutical / Industry Protocol IDs: OXN12-KR-402, NCT01675531
3.	Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0309006308, NCT00195013
4.	Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients Phase: Phase III Type: Natural history/Epidemiology, Supportive care Status: Approved-not yet active Age: 18 to 75 Sponsor: Other Protocol IDs: Version 1.1, NCT00872352
5.	Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000654709, RTOG-0724, NCT00980954
6.	Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000696704, CRUK-KPS-2008-01, EU-21012, EUDRACT-2007-002080-27, ISRCTN-49116945, NCT01316744
7.	Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Phase: Phase III Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000719317, GOG-0257, NCT01492920
8.	Prevention of Oxaliplatin-induced Neuropathic Pain by a Specific Diet Phase: Phase III Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 to 70 Sponsor: Other Protocol IDs: CHU-0137, 2011-A00911-40, NCT01775449
9.	Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NUALA-01, STU00041525, NCT01313117
10.	Acupuncture CIPN IRG Phase: Phase II, Phase I Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2012-1054, NCT01815346
11.	Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study) Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CCR3116, NCT01278004
12.	Prevention of Treatment Induced Neuropathy in Multiple Myeloma Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2006-0022, NCT01283997
13.	Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL) Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 1 to 18 Sponsor: Other Protocol IDs: TINALL, NCT01506453
14.	Characterization and Treatment of Chemotherapy Neuropathy Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: R01CA151692, NCT01557608
15.	Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CASE2A10, NCI-2011-01866, NCT01783522
16.	The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: TTX-CINP-201, NCT01655823
17.	Acupuncture Study for the Prevention of Taxane Induced Myalgias and Neuropathy Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: AAAE7054, NCT01163682
18.	Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy Phase: Phase I Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: IRB/COSA # 079-12, NCT01682499
19.	N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LTC-510-100108-Bahce, CCMO: NL19614.091.07, EudraCT: 2007-002787-95, NCT00637624
20.	European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EudraCT 2007-003968-22, ISRCTN45967602, NCT00700531
21.	Longitudinal Study of Symptoms in Colorectal Cancer Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2007-0637, NCT00777192
22.	Heading Off Peripheral Neuropathy With Exercise Phase: No phase specified Type: Supportive care Status: Approved-not yet active Age: 19 and over Sponsor: Other Protocol IDs: 478-08-FB, NCT00869804
23.	Skin Biopsies in Chemotherapy-Induced Neuropathy Phase: No phase specified Type: Diagnostic, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MEC2008-305, NCT00956033
24.	Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 10CC03, NCI-2010-02105, STU00033028, NCT01243541
25.	Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LCCC1027, 10-2121, NCT01305954